Peptic Ulcer Drugs; Treatment Usually Includes Medication to Decrease Stomach Acid Production

 

Peptic Ulcer Drugs Market
Peptic Ulcer Drugs

There are several types of peptic ulcer drugs used to treat a peptic ulcer. A doctor will decide the best treatment based on the underlying cause of the peptic ulcer. Proton pump inhibitors (esomeprazole (Nexium), pantoprazole (Protonix), lansoprazole (Prevacid), dexlansoprazole (Dexilant), omeprazole (Prilosec, Zegerid), and rabeprazole (AcipHex)), histamine receptor blockers (cimetidine (Tagamet), ranitidine (Zantac), famotidine (Pepcid), and nizatidine (Axid) Protectants), and protectants can help relieve pain and help ulcer heal.

The Global Peptic Ulcer Drugs Market is estimated to account for US$ 45,951.2 Mn in terms of value by the end of 2027.

A peptic ulcer is an open sore that develop on the inside lining of the stomach and the upper portion of the small intestine. Peptic ulcers are of two types, such as duodenal ulcers and gastric ulcers. Symptoms of stomach ulcer include pain in the stomach, loss of appetite, weight loss, vomiting or nausea, bloating, burping or acid reflux, heartburn, etc. Treatment usually includes peptic ulcer drugs to decrease stomach acid production. Proton pump inhibitors (PPI) reduce stomach acid by blocking the action of the parts of cells that produce acid.

PPIs are the gold standard in medication therapy of peptic ulcer disease. Peptic ulcer drugs help protect and strengthen mucous lining of the stomach. Antibiotics to treat H. Antibiotics may be required if it is caused by bacteria. Peptic ulcers caused by the bacteria Helicobacter pylori (H. pylori) are usually treated with a combination of antibiotics that kill the bacteria as well as other drugs to reduce stomach acid and protect the stomach lining. Antibiotics can cure most peptic ulcers caused by H. pylori. However, getting rid of the bacteria can be difficult.

Protectants coat ulcers and protect them against acid and enzymes so that healing can occur. A doctors only prescribe one protectant, sucralfate (Carafate) link, for peptic ulcer disease. Peptic ulcer is very common and affects more than 4 million people each year in the U.S., and thus, there is an increasing demand for peptic ulcer drugs in this region.

Comments

Popular posts from this blog

Rising lymphocytic leukemia to augment Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Growth

Health Caregiving; used to help in daily activities

Rising Technological Developments To Boost Ultrasonic Non-Destructive Testing (NDT) Equipment Market Growth